Conversely, when lung cancer cells were treated with miR-218 antagomirs, levels of miR-218 were decreased (Fig. 4G), but the amount of CDCP1 protein was increased in lung cancer cells at 48 h after miR-218 antagomirs transfection (Fig. 4H). This evidence concerns the gene CDCP1 and lung cancer.